Results 1 to 10 of about 4,155 (158)

The role of ixekizumab in non-radiographic axial spondyloarthritis [PDF]

open access: yesTherapeutic Advances in Musculoskeletal Disease, 2021
Among patients with axial spondyloarthritis (axSpA), non-radiographic axial spondyloarthritis (nr-axSpA) is distinguished from ankylosing spondylitis (AS) by a lack of obvious radiographic changes in the sacroiliac joint. Tumor necrosis factor inhibitor (
Bon San Koo, Tae-Hwan Kim
doaj   +5 more sources

A tale about an unusual cause of pygalgia in non‐radiographic axial spondyloarthritis [PDF]

open access: yesClinical Case Reports, 2023
Schwannoma are tumors of Schwann cells of the peripheral nerve sheath. Sacral location is rarely reported especially in spondyloarthritis patients. Herein, we report a case of uncommon pygalgia in a 25‐year‐old man with history of a non‐radiographic ...
Rim Dhahri   +9 more
doaj   +4 more sources

Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis [PDF]

open access: yesFrontiers in Immunology, 2021
ObjectiveEvaluate the MRI evidence of active inflammatory and chronic structural damages in radiographic axial spondyloarthritis (r-axSpA) and non-radiographic axial spondyloarthritis (nr-axSpA).MethodsA retrospective review of 253 patients who underwent
Liudan Tu   +6 more
doaj   +5 more sources

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort [PDF]

open access: yesScientific Reports
To compare the demographic, clinical, and laboratory characteristics, disease onset, and clinical features of radiographic axial Spondyloarthritis (r-axSpA) and non-radiographic axial Spondyloarthritis (nr-axSpA) patients.
John Londono   +12 more
doaj   +5 more sources

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy [PDF]

open access: yesRheumatology and Therapy, 2019
Non-radiographic axial spondyloarthritis (nr-axSpA) is a recently described form of axial inflammatory arthritis that has not caused substantial erosive damage to the sacroiliac joints.
Philip C. Robinson   +2 more
doaj   +9 more sources

Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks [PDF]

open access: yesBMC Rheumatology, 2021
Background Patients with non-radiographic axial spondyloarthritis experience negative impacts on sleep, work productivity, and activity impairment. Ixekizumab, a monoclonal antibody selectively targeting interleukin-17A, has shown efficacy in treating ...
Atul Deodhar   +8 more
doaj   +2 more sources

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis [PDF]

open access: yesArthritis Research & Therapy, 2023
Background Radiographic progression and course of inflammation over 2 years in patients with non-radiographic axial spondyloarthritis (nr-axSpA) from the phase 3, randomized, PREVENT study are reported here.
Juergen Braun   +14 more
doaj   +2 more sources

Disease course of non-radiographic axial spondyloarthritis: Data from a long-term retrospective observational cohort. [PDF]

open access: yesPLoS ONE, 2023
BackgroundDisease course of non-radiographic axial spondyloarthritis (axSpA) has been extensively studied in non-Asian population; however, there are limited data in Asian population.
Oh Chan Kwon   +2 more
doaj   +2 more sources

A Case of a Non-Radiographic Axial Spondyloarthritis in a 14-Year-Old Girl Presenting with Muscle Weakness and Hyperthyroidism [PDF]

open access: yesInternational Medical Case Reports Journal, 2020
Abdullah Elhosiny,1 Renad Alshoubaki,1 Lama Sindi,2 Sadeem Bukhari,2 Hani Almoallim1,2 1Department of Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia; 2Department of Medicine, Faculty of Medicine, Umm Alqura University, Makkah, Saudi ...
Elhosiny A   +4 more
doaj   +2 more sources

Use and Switching of Biologic Therapy in Patients with Non-Radiographic Axial Spondyloarthritis: A Patient and Provider Survey in the United States [PDF]

open access: yesRheumatology and Therapy, 2020
Introduction The Food and Drug Administration (FDA) approved certolizumab-pegol, the first biologic for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA), for use in the United States (US) in March of 2019.
Atul Deodhar   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy